IDEAS home Printed from https://ideas.repec.org/a/kap/jbuset/v123y2014i1p145-155.html
   My bibliography  Save this article

Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising

Author

Abstract

Advertisements for pharmaceuticals may promote placebo responses by generating an expectation of therapeutic success. Some cite this as reason to favour Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA). Against this, I show placebo responses to emanate from beliefs rendered unjustified by the influence of a conditioning process. I argue that drug safety and efficacy are material properties and that unjustified beliefs in these domains entail costs to autonomy that outweigh any prudential gains attending a placebo response. I conclude that its placebogenic potential ought not to count as reason to favour DTCA. Copyright Springer Science+Business Media Dordrecht 2014

Suggested Citation

  • Paul Biegler, 2014. "Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising," Journal of Business Ethics, Springer, vol. 123(1), pages 145-155, August.
    • Handle: RePEc:kap:jbuset:v:123:y:2014:i:1:p:145-155
    DOI: 10.1007/s10551-013-1805-0
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10551-013-1805-0
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10551-013-1805-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Steven Sweldens & Stijn M. J. Van Osselaer & Chris Janiszewski, 2010. "Evaluative Conditioning Procedures and the Resilience of Conditioned Brand Attitudes," Journal of Consumer Research, Journal of Consumer Research Inc., vol. 37(3), pages 473-489, October.
    2. Elizabeth A Almasi & Randall S Stafford & Richard L Kravitz & Peter R Mansfield, 2006. "What Are the Public Health Effects of Direct-to-Consumer Drug Advertising?," PLOS Medicine, Public Library of Science, vol. 3(3), pages 1-1, March.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alexander Nill & Gene Laczniak, 2022. "Direct-to-Consumer Genetic Testing and Its Marketing: Emergent Ethical and Public Policy Implications," Journal of Business Ethics, Springer, vol. 175(4), pages 669-688, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pepijn Pol & Frank Bakker, 2010. "Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?," Journal of Business Ethics, Springer, vol. 94(2), pages 211-224, June.
    2. Frosch, Dominick L. & May, Suepattra G. & Tietbohl, Caroline & Pagán, José A., 2011. "Living in the “land of no”? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs," Social Science & Medicine, Elsevier, vol. 73(7), pages 995-1002.
    3. Galina Biedenbach & Thomas Biedenbach & Peter Hultén & Veronika Tarnovskaya, 2022. "Organizational resilience and internal branding: investigating the effects triggered by self-service technology," Journal of Brand Management, Palgrave Macmillan, vol. 29(4), pages 420-433, July.
    4. Ram Bala & Pradeep Bhardwaj, 2010. "Detailing vs. Direct-to-Consumer Advertising in the Prescription Pharmaceutical Industry," Management Science, INFORMS, vol. 56(1), pages 148-160, January.
    5. Levaggi, Rosella & Orizio, Grazia & Domenighini, Serena & Bressanelli, Maura & Schulz, Peter J. & Zani, Claudia & Caimi, Luigi & Gelatti, Umberto, 2009. "Marketing and pricing strategies of online pharmacies," Health Policy, Elsevier, vol. 92(2-3), pages 187-196, October.
    6. Guy David & Sara Markowitz & Seth Richards-Shubik, 2010. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," American Economic Journal: Economic Policy, American Economic Association, vol. 2(4), pages 1-25, November.
    7. Anne-Madeleine Kranzbühler & Mirella H. P. Kleijnen & Peeter W. J. Verlegh, 2019. "Outsourcing the pain, keeping the pleasure: effects of outsourced touchpoints in the customer journey," Journal of the Academy of Marketing Science, Springer, vol. 47(2), pages 308-327, March.
    8. Keith J. Zullig & Amanda L. Divin, 2022. "Quantifying Healthy Days Lost to the Non-Medical Use of Prescription Drugs (NMUPD) among a Sample of College Students," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 17(2), pages 655-669, April.
    9. Geoffrey Fisher & Matthew McGranaghan & Jura Liaukonyte & Kenneth C. Wilbur, 2023. "Price promotions, beneficiary framing, and mental accounting," Quantitative Marketing and Economics (QME), Springer, vol. 21(2), pages 147-181, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:jbuset:v:123:y:2014:i:1:p:145-155. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.